Thursday, April 10, 2008

Unlikely Potential Winner Emerges from Vytorin Collapse. . . .


And, it may very well turn out to be all generic makers of statins, or perhaps, Astra Zeneca PLC, and its Crestor. Could it be?



We'll see. Cheers!

No comments: